Authors
Loading...
Preclinical drug evaluation reveals novel indazole benzenesulfonamide derivatives as potent PLK4 inhibitors, highlighting potential pathways to modulate mitosis and maintain genomic integrity.
Sun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: